Skip to NavigationSkip to content

News

The FDA has given the go-ahead for two hepatitis C treatments for use in young and adolescent patients: Sovaldi (sofosbuvir) and Harvoni (...
Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have managed to harness a virus to...
The EMA has ruled that the five patient deaths that occurred in February of this year were not directly related to Actelion’s Uptravi and it was...
Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial assessing its efficacy as a...
Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a...
Novartis has announced that its eyecare-focused division Alcon has in-licensed dry-eye drug ECF843 from US firm Lubris for ophthalmic indications...
Zavante, a biotech company based in San Diego, has unveiled positive results from a recent Phase II/III trials that could see an antibiotic commonly...
Huge product recalls for GSK and Mylan, and a surprising new breakthrough in PTSD treatment - check out our Top Ten most popular articles this week.
A new clinical study by researchers at the University of Pennsylvania have found links between the practice of yoga and the reduction or removal...
Intelligence firm GlobalData provides an overview of the risk factors, comorbidities, and the global and historical trends for brain cancer across...